1. Home
  2. GPRK vs ETON Comparison

GPRK vs ETON Comparison

Compare GPRK & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geopark Ltd

GPRK

Geopark Ltd

HOLD

Current Price

$10.04

Market Cap

608.0M

Sector

Energy

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$26.82

Market Cap

683.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRK
ETON
Founded
2002
2017
Country
Colombia
United States
Employees
382
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
608.0M
683.7M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
GPRK
ETON
Price
$10.04
$26.82
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$8.50
$39.33
AVG Volume (30 Days)
1.4M
468.4K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$79,950,000.00
Revenue This Year
$39.45
$40.90
Revenue Next Year
N/A
$47.23
P/E Ratio
$12.70
N/A
Revenue Growth
N/A
104.94
52 Week Low
$5.75
$13.09
52 Week High
$10.34
$27.19

Technical Indicators

Market Signals
Indicator
GPRK
ETON
Relative Strength Index (RSI) 61.05 72.12
Support Level $7.84 $16.38
Resistance Level $10.16 N/A
Average True Range (ATR) 0.53 1.28
MACD 0.03 0.08
Stochastic Oscillator 89.12 90.65

Price Performance

Historical Comparison
GPRK
ETON

About GPRK Geopark Ltd

GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: